Loading...
Cadila Healthcare Ltd — Chloroquine Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #4 for Chloroquine · $700.0K export value · DGFT Verified
Cadila Healthcare Ltd is the #4 Indian exporter of Chloroquine with $700.0K in export value and 14 verified shipments. Cadila Healthcare Ltd holds a 0.4% market share in Chloroquine exports across 4 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.9M | 39 | 74.0% |
| VIETNAM | $300.0K | 6 | 11.4% |
| THAILAND | $288.7K | 7 | 11.0% |
| HONG KONG | $50.0K | 1 | 1.9% |
| SRI LANKA | $35.5K | 1 | 1.3% |
| BOLIVIA | $10.2K | 1 | 0.4% |
Cadila Healthcare Ltd exports Chloroquine to 6 countries. The largest destination is UNITED STATES accounting for 74.0% of Cadila Healthcare Ltd's Chloroquine shipments, followed by VIETNAM (11.4%) and THAILAND (11.0%). These destinations reflect Cadila Healthcare Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $1.8M | 36 |
| KASPA PHARMACEUTICAL THAILAND | THAILAND | $179.8K | 4 |
| HAPHARCOJ S CBRANCH | VIETNAM | $150.0K | 3 |
| NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $100.0K | 2 |
| HAPHARCO J S C BRANCH CHI MINH CITY | VIETNAM | $100.0K | 2 |
| KASPA PHARMACEUTICAL THAILAND CO LTD | THAILAND |
India exported $40.7M worth of Chloroquine through 5,437 shipments from 287 suppliers to 120 countries, serving 774 buyers globally. Cadila Healthcare Ltd contributes $700.0K to this total, accounting for 0.4% of India's Chloroquine exports. Cadila Healthcare Ltd ships Chloroquine to 6 countries through 12 buyers.
Cadila Healthcare Ltd's average Chloroquine shipment value is $50.0K per consignment, based on 14 shipments totaling $700.0K. The largest destination is UNITED STATES (74.0% of Cadila Healthcare Ltd's Chloroquine exports).
Cadila Healthcare Ltd ranks #4 among 287 Indian Chloroquine exporters with a 0.4% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($19.1M), ZYDUS LIFESCIENCES LIMITED ($13.0M), CADILA HEALTHCARE LIMITED ($2.0M). Cadila Healthcare Ltd processed 14 shipments to 4 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA : HYDROXYCHLOROQUINE SULFATE TABL | $450.0K | 9 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 2 | $200.0K | 4 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X100 PER PACK] | $200.0K | 4 |
| HCQ HYDROXYCHLOROQUINE SULPHATE USP 200MG 10 X 10'S | $200.0K | 4 |
| ZYQUENIL HYDROXYCHLOROQUINE SULFATE TAB | $158.9K | 4 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG DIST. NDC - 68382-096-01 MANUFACTURING . NDC -65841-633-01 AS PER INVOICE. & P.LIST | $150.0K | 3 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1X100T | $150.0K | 3 |
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X500 PER PACK] | $150.0K | 3 |
What Cadila Healthcare Ltd must comply with to export Chloroquine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | NITIN LIFESCIENCES LIMITED | $854.3K | 50 | 1 | $17.1K |
| 9 | SYNCOM FORMULATIONS (INDIA) LIMITED | $713.0K | 113 | 7 | $6.3K |
| 4 | CADILA HEALTHCARE LTD ★ | $700.0K | 14 | 4 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $700.0K | 14 | 1 | $50.0K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,431 | 26.3% |
| SAHAR AIR | 1,199 | 22.1% |
| DELHI AIR CARGO ACC (INDEL4) | 657 | 12.1% |
| Bombay Air | 359 | 6.6% |
| DELHI AIR | 325 | 6.0% |
| MUNDRA SEA | 156 | 2.9% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.5% |
| Delhi Air | 127 | 2.3% |
Latest developments and market context
Detailed market intelligence for Chloroquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Healthcare Ltd's Chloroquine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| $79.8K |
| 2 |
| HAPHARCO J S C BRANCH | VIETNAM | $50.0K | 1 |
| PRIORITY HEALTHCARE DISTRIBUTION DB | UNITED STATES | $50.0K | 1 |
| CHEMILL PHARMA LIMITED | HONG KONG | $50.0K | 1 |
| SUNSHINE HEALTHCARE LANKA LIMITED | SRI LANKA | $35.5K | 1 |
Cadila Healthcare Ltd supplies Chloroquine to 12 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by KASPA PHARMACEUTICAL THAILAND (THAILAND) and HAPHARCOJ S CBRANCH (VIETNAM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG | $100.0K | 2 |
| ZYQUENIL HYDROXYCHLOROQUINE SULFATE TABS USP 200MG 10 X 10T | $79.8K | 2 |
Cadila Healthcare Ltd exports 27 distinct Chloroquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA : HYDROXYCHLOROQUINE SULFATE TABL with 9 shipments worth $450.0K.
| 10 | CARITAS HEALTHCARE PRIVATE LIMITED | $523.4K | 11 | 1 | $47.6K |
Cadila Healthcare Ltd ranks #4 among 287 Indian Chloroquine exporters. Average shipment value of $50.0K compared to the market average of $141.7K. The closest competitors by value are NITIN LIFESCIENCES LIMITED and SYNCOM FORMULATIONS (INDIA) LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 774+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Cadila Healthcare Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Chloroquine. For current shipment-level data, contact TransData Nexus.